Skip to main content

Monoclonal Antibodies against 2019-New Coronavirus

Project description

Monoclonal antibodies against COVID-19

Previous experience on SARS and MERS coronaviruses is proving instrumental for the rapid development of new diagnostic, prophylactic and therapeutic intervention strategies against COVID-19. The EU-funded MANCO project is building on technology generated during the ongoing IMI-funded ZAPI project on monoclonal antibodies against coronaviruses. The researchers of MANCO will identify specific monoclonal antibodies against the new coronavirus and validate them at the preclinical level. The idea is to advance one lead prophylactic and/or therapeutic monoclonal antibody into a Phase I clinical trial and make results available within two years of the start of the project.

Field of science

  • /medical and health sciences/health sciences/infectious disease/RNA virus/coronavirus

Call for proposal

H2020-SC1-PHE-CORONAVIRUS-2020
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Address
Dr Molewaterplein 40
3015 GD Rotterdam
Netherlands
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 351 250

Participants (7)

HARBOUR ANTIBODIES BV
Netherlands
EU contribution
€ 100 000
Address
Stationsplein 45, A4.004
3013 AK Rotterdam
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITEIT UTRECHT
Netherlands
EU contribution
€ 219 627,50
Address
Heidelberglaan 8
3584 CS Utrecht
Activity type
Higher or Secondary Education Establishments
STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER
Germany
EU contribution
€ 130 000
Address
Bunteweg 2
30559 Hannover
Activity type
Higher or Secondary Education Establishments
AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS
Spain
EU contribution
€ 125 001,25
Address
Calle Serrano 117
28006 Madrid
Activity type
Research Organisations
ASSOCIATION INTERNATIONALE DE STANDARDISATION BIOLOGIQUE POUR L'EUROPE(IABS-EU)
France
EU contribution
€ 131 625
Address
Boulevartd Vivier Merle 10-12 World Trade Center Tour Oxygene
69393 Lyon
Activity type
Other
CR2O BV
Netherlands
EU contribution
€ 1 803 827,50
Address
Bisonspoor 3002, C701
3605 LT Maarssen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
FINOVATIS
France
EU contribution
€ 173 250
Address
Cours Lafayette 68
69003 Lyon
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)